Sukhbinder Dhesy‐Thind

PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy

Sharlene Gill, Yoo‐Joung Ko, C. Cripps et al. · Journal of Clinical Oncology · 2016 · 291 citations

Medicine, Oncology, Pharmacotherapy +13

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update

Catherine Van Poznak, Mark R. Somerfield, William E. Barlow et al. · Journal of Clinical Oncology · 2017 · 180 citations

Medicine, Oncology, Pharmacotherapy +17

A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.

Vanessa Bernstein, Susan Ellard, Susan Dent et al. · Breast Cancer Research and Treatment · 2017 · 101 citations

Medicine, Oncology, Pharmacology +14

Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours

Mira M. Shenouda, Amy Gillgrass, Tina Nham et al. · Breast Cancer Research · 2017 · 79 citations · Full text

Life Sciences, Immunology, Oncology +17

Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors

Ana L. Portillo, Richard T. Hogg, Sophie M. Poznanski et al. · iScience · 2021 · 70 citations · Full text

Life Sciences, Immunology, Oncology +17